[HTML][HTML] A Review of the Effects of Fucoxanthin on NAFLD

NH Sayuti, KN Muhammad Nawawi, JA Goon… - Nutrients, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease.
Fucoxanthin, a red-orange marine carotenoid, is found in natural marine seaweeds with …

[HTML][HTML] Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy

F Khaznadar, A Petrovic, O Khaznadar… - Journal of clinical …, 2023 - mdpi.com
In the current modern era of unhealthy lifestyles, non-alcoholic fatty liver disease (NAFLD) is
the most prevalent liver disease and has become a serious global health problem. To date …

[HTML][HTML] TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice

K Burger, F Jung, A Baumann, A Brandt, R Staltner… - Redox Biology, 2023 - Elsevier
Tumor necrosis factor alpha (TNFα) is thought to be a critical factor in the development of
metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we determined the …

Association of long-term ambient fine particulate matter (PM2. 5) and incident non-alcoholic fatty liver disease in Chinese adults

P Deng, H Tang, L Zhu, J Duan, F Li, Y Li, J Wang… - Environmental …, 2023 - Elsevier
Air pollution is increasingly recognized as an important environmental risk factor for non-
alcoholic fatty liver disease (NAFLD). However, epidemiologic evidence on long-term …

[HTML][HTML] Association between weight-adjusted waist index and non-alcoholic fatty liver disease: a population-based study

C Yu, S He, M Kuang, C Wang, X Huang… - BMC Endocrine …, 2024 - Springer
Background Obesity is the most important driver of non-alcoholic fatty liver disease (NAFLD);
nevertheless, the relationship of weight-adjusted waist index (WWI), a new obesity index …

[HTML][HTML] Dietary supplementation with 20-hydroxyecdysone ameliorates hepatic steatosis and reduces white adipose tissue mass in ovariectomized rats fed a high-fat …

J Buniam, P Chansela, J Weerachayaphorn… - Biomedicines, 2023 - mdpi.com
Metabolic dysfunction-associated fatty liver disease (MAFLD) is defined as hepatic steatosis
in combination with overweight, diabetes, or other metabolic risk factors. MAFLD affects a …

[HTML][HTML] The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease

MI Elsaid, JFP Bridges, K Mumtaz, N Li, L Sobotka… - Plos one, 2024 - journals.plos.org
Background & aims Previous studies have examined the effects of metabolic syndrome
(MetS) rather than its severity on race and ethnic disparities in Metabolic Dysfunction …

[HTML][HTML] Lean nonalcoholic fatty liver disease and sarcopenia

M Chen, Y Cao, G Ji, L Zhang - Frontiers in Endocrinology, 2023 - frontiersin.org
Nonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver
diseases in the world. The risk factor for NAFLD is often considered to be obesity, but it can …

[HTML][HTML] Associations Between Active, Passive Smoking and the Risk of Nonalcoholic Fatty Liver Disease

X Ge, J Lu, C Yu, W Guo, T Tian, X Xu… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with an
estimated worldwide prevalence of 32.4%. 1 The multisystem condition is related to an …

Pathophysiological Features of Rat Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Y Saigo, K Uno, T Ishigure, T Odake, T Ohta - in vivo, 2024 - iv.iiarjournals.org
Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) is caused by
various factors, including genetic and/or environmental factors, and has complicated …